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Viral DNA in renal biopsy tissue from HIV infected patients with
nephrotic syndrome. Focal glomerulosclerosis (FGS) has been consid-
ered as HI V-associated nephropathy, a specific renal complication of
infection. To determine whether renal disease in HIV infected patients
has one highly prevalent pathologic expression, and whether renal
parenchymal viral genomic incorporation affects pathologic outcome,
we reviewed renal biopsies performed at our center. Twenty-eight HIV
infected patients with nephrotic range proteinuria underwent renal
biopsy for diagnosis of renal disease; 85.7% led homosexual or bisexual
lifestyles; 10.7% admitted to intravenous drug use; and 85.7% were
Black. Only 53.6% had FGS; 28.6% had glomerulonephritis. Two
patients had diabetic renal disease; 93.3% of patients with FGS and
87.5% of patients with glomerulonephritis were Black. Paraffin slides of
twenty-two of the patients' renal biopsies were evaluated by poly-
merase chain reaction (PCR) for the presence of HIV DNA, using
primers and probes to the gag gene, detected by liquid hybridization and
polyacrylamide gel electrophoresis. Twenty-one of the twenty-two
evaluated tissue specimens showed the presence of HIV DNA. Micro-
dissection studies of glomeruli, tubules, interstitial cells and infiltrating
inflammatory cells showed the presence of HIV genome in all but
interstitial cells. HIV infected patients without renal disease also had
positive PCR evaluations of microdissected tissue, while non-infected
patients were all negative. We conclude that although focal glomerulo-
sclerosis is the most common renal pathologic lesion in patients with
HIV infection and nephrotic range proteinuna, glomerulonephritis is a
relatively frequent finding. HIV genome is present in renal tissue in
HIV infected subjects with nephrotic range proteinuria, but is also
found in HIV infected subjects without nephropathy. These data
suggest a triggering mechanism may be crucial to the pathogenesis of
nephropathy in HIV infected patients. Renal biopsy is essential to
establishing the diagnosis of HIV-associated renal disease in this
heterogeneous syndrome. The role of renal HIV infection, the cell types
affected, and influence on pathogenesis of renal disease remain to be
detennined.
Several renal pathologic entities have been associated with
human immunodeficiency virus (HIV) infection, although their
pathogenesis remains unknown [1—17]. The most common is
focal glomerulosclerosis (FGS) [1—8, 17], although several dif-
ferent types of glomerulonephritis have been observed in pa-
tients with HIV infection and the acquired immunodeficiency
syndrome (AIDS) [9—16]. Renal histologic findings noted in
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patients with HIV infection and chronic renal dysfunction and
nephrotic syndrome, such as membranoproliferative glomeru-
lonephritis, membranous glomerulonephritis, or other patholog-
ical findings suggestive of immune complex mediated etiology
have been reported [9—17]. HIV related antigen-antibody com-
plexes are commonly found in patients with HIV infection, or
AIDS [18—24]. We recently evaluated patients with HIV infec-
tion, and clinical signs and symptoms associated with glomer-
ulonephritis. Identical immune complexes could be isolated
from the circulation and renal eluates in such patients [25]. In
addition, we recently evaluated patients with HIV infection and
IgA nephropathy, in which identical immune complexes were
isolated from the circulation and from renal eluates [16].
Investigators have suggested that HIV gene products may be
found in renal biopsies of patients with HIV infection and renal
disease, although the role of their renal cellular incorporation in
the development of renal disease is unknown [261. In earlier
studies, we demonstrated that polymerase chain reaction (PCR)
techniques could identify HIV genomic material in renal biopsy
tissue from HIV infected patients with renal disease [16, 25]. In
order to determine whether renal disease in HIV infected
patients has one highly prevalent pathological expression, and
whether renal parenchymal viral genomic incorporation affects
pathological outcome, we reviewed the renal biopsies per-
formed at the George Washington University Medical Center in
patients with HIV infection and nephrotic range proteinuria.
We examined the renal biopsies using PCR, and established a
microdissection technique to enhance the specificity and inter-
pretation of our findings.
Methods
Patients
Twenty-eight patients with AIDS or HIV infection and ne-
phrotic range proteinuria were evaluated and underwent renal
biopsy at the George Washington University Medical Center for
diagnosis of renal disease between January 1986 and June 1992.
All patients had 24-hour urinary protein excretion of greater
than 2.8 g. The demography of our patient population has been
previously described [27]. Approximately two-thirds of our
HIV infected population are Black and one-third White. All
patients gave their informed consent for the procedure.
Kidney biopsies from ten patients without known risk factors
for the development of AIDS were used as control specimens.
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Patients were matched, as far as possible, for pathologic
diagnosis with HIV infected patients with renal disease. Kidney
tissue from autopsies from five HIV infected patients without
pathological evidence of renal disease were also evaluated.
Histopathology
Renal tissue specimens were paraffin embedded and a portion
of the specimens were separated for molecular biology studies.
Five micron sections of the renal biopsies were cut in a
microtome and stained with hematoxylin-eosin, periodic acid
Schiff, periodic acid methenamine silver, and Masson's tn-
chrome stain for immunohistochemical and electron micro-
scopic studies as previously described [161. To avoid any
cross-contamination between cases, a new blade was used
every time a new case was sectioned. The tissue was prepared
for PCR as previously described [16].
Eight 5-micron sections from kidney biopsies were scraped
from paraffin embedded kidney biopsies. DNA was extracted
from sections of renal biopsies using a modified Higuchi method
[28] as previously described [16, 29].
Microdissection
Intact glomeruli, and tubular, interstitial, and infiltrating
inflammatory cells were selectively obtained from glass-slide-
mounted paraffin-embedded kidney biopsies by microdissec-
tion. Cells were microdissected with a set of Narishige (Image
Systems, Columbia, Maryland, USA) mechanical and hydraulic
micromanipulators and microinjectors coupled to a Nikon
(Melville, New Jersey, USA) inverted microscope. Glomeruli,
and tubular, interstitial and infiltrating cells were identified
morphologically by direct light microscopic examination. Spe-
cial emphasis was placed on obtaining intact glomeruli and
tubular cells without any adherent interstitial or inflammatory
cells. Each microdissected glomerulus, two to three tubules,
and 12 to 15 interstitial or infiltrating cells were placed in
separate tubes. Biopsies from patients without known risk
factors for developing AIDS were microdissected after every
study of a biopsy from an HIV infected patient. This procedure
of alternating microdissection of the kidney biopsies from HIV
infected patients with kidney biopsies from uninlected patients
was performed in order to control for any cross-contamination
between specimens.
Glass micropipettes were prepared with a Narishige pipette
puller and changed each time a new type of cell or case was
microdissected. The teflon tubing and the pipette holder were
exposed to UV light for 20 minutes and washed by flushing
them with 500 ml of HPLC grade water every time tissue from
a new case was microdissected. Once the cells were microdis-
sected, they were each transferred to 500 sl reaction tubes
under direct microscopic observation to verily the presence of
microdissected cells inside and at the bottom of the tubes.
Subsequently 450 jsl of 100% ethanol was added to the tubes.
They were centrifuged at 15,000 rpm in an Eppendorf (Brink-
mann, Westbury, New York, USA) microcentrifuge for 30
minutes. The ethanol was evaporated in a Speed Vac (Savant,
Farmingdale, New Jersey, USA) microcentrifuge. The micro-
scope, micromanipulator and microinjectors were located in a
room completely separated from the pre- and post-PCR rooms
to avoid any contamination with PCR products [29].
Nucleic acid extraction
Following ethanol evaporation, the cells were resuspended in
75 l of PCR buffer to which 0.5% Nonidet P40 and 0.5% Tween
20 (Sigma, St. Louis, Missouri, USA) were added. Extraction
of DNA from microdissected cells was achieved by heating the
contents of the reaction tube in boiling water for 15 minutes.
Polymerase chain reaction
A nested PCR procedure, previously described [29], was
performed to amplify target sequences within the gag region of
the HIV- 1 proviral genome. To assure the presence of micro-
dissected cells and that the reaction was not inhibited by the
sample, a region from exon 1 of the human cardiac myosin
heavy chain (MyHC) gene was amplified from the samples. The
primers used for the amplification of the gag gene were SK100
and SK1O5 for the outer nest, and SK18 and SK39 for the inner
nest. For the MyHC gene, MyHC1 and MyHC2 were used for
the outer nest, and MyHC2O and MyHC4O were used for the
inner nest, The amplification reaction for the outer and inner
nests was repeated 40 times. Each cycle consisted of denatur-
ation for one minute at 92°C, annealing for 2.5 minutes at 52°C,
and extension for three minutes at 72°C. This resulted in the
amplification of a 137 bp fragment for the gag gene and a 185 bp
fragment for the MyHC gene. After liquid hybridizing the inner
nest reaction product with an end labeled probe (SK19 for the
gag gene and MyHC3O for the MyHC gene), the samples were
run on a 10% polyacrylamide gel, using PhiX as a molecular
weight marker. The gels were exposed to X-ray film for the
visualization of bands. Several control samples were amplified
simultaneously with the DNA from renal biopsies, including a
reagent control that contained no DNA template, a negative
control containing DNA known to be negative for HIV and
dilutions of a plasmid containing a 9 Kb fragment of the HIV
genome [30]. Reagents were prepared and microdissected cells
extracted in a separate pre-PCR area.
Results
All but one of the patients were male. A total of 85.7% were
homosexual or bisexual; 10.7% were intravenous drug users;
and 85.7% of the patients were Black. The patients' renal
pathologic diagnoses are outlined in Table 1.
A total of 53.6% of the patients had FGS with varying degrees
of tubulointerstitial inflammatory infiltrate, 93.3% of the pa-
tients with FGS were Black, and 28.6% of the patients had a
form of proliferative glomerulonephritis. These included focal
proliferative, membranoproliferative and diffuse proliferative
glomerulonephritis, and IgA nephropathy with focal prolifera-
tive changes. Of the patients with glomerulonephritis 87.5%
were Black. Four patients (14.2%) had acute tubular necrosis
complicating another renal disease. Two patients with long-
standing diabetes mellitus and HIV infection had pathologic
findings suggestive of diabetic nephropathy. One patient had
membranous nephropathy suggestive of secondary disease as-
sociated with hepatitis B virus infection, one had minimal
change disease, and one had mesangial proliferation and inter-
stitial cryptococcal microabscesses.
Twenty-two of the 28 HIV infected patients with nephrotic
range proteinunia had renal biopsy tissue available for evalua-
tion for the presence of HIV genome by PCR (Table 1). HIV-l
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Table 1. Nephrotic syndrome in HIV infected patients
No. Race Sex Age Risk factor Diagnosis
U Prot
g/24 hr PCR
1 B M 27 HMS FGS 2.8 (+)
2 B M 46 HMS FGS/TIN 3.8 (ND)
3 B M 23 HMS FGS/TIN 4.8 (ND)
4 B M 34 HMS FUS/TIN 4.0 (ND)
5 B M 45 HTS/IVDU FGS/TIN 13.7 (—)6 B M 34 HTS/IVDU FGS/TIN 5.3 (+)
7 B M 33 HTS/IVDU FGS/TIN 9.8 (+)
8 B M 27 HMS FGS/TIN 4.6 (ND)
9 B M 27 HMS FGS/TIN 11.7 (+)
10 B M 30 HMS FGS/TIN 10.2 (+)
11 B F 24 HTS FGS/TIN 3.7 (ND)
12 W M 48 HMS FGS/TIN 8.6 (+)
13 B M 38 HMS FGS/TIN/ATN 8.9 (+)
14 B M 29 HMS FGS/TIN/ATN 9.0 (+)
15 B M 48 HMS FTSITIN/TX 5.5 (+)
16 B M 29 HMS FPGN/TIN 11.1 (+)
17 B M 31 HTS FPGN/TIN 5.9 (+)
18 B M 34 BIS FPGN/TIN 22.0 (+)
19 B M 34 HMS FPGN 22.0 (+)
20 B M 39 HMS FPGN 3.4 (ND)
21 B M 31 HMS MPGN 6.8 (+)
22 B M 55 BIS DPGN 29.4 (+)
23 W M 26 HMS IgA 3.9 (+)
24 W M 29 HMS MN 14.0 (+)
25 B M 36 HMS MCD, ATN 3.4 (+)
26 W M 31 HMS DM/TIN 8.9 (+)
27 B M 28 HMS DM 3.7 (+)
28 B M 29 HMS ATN, Crypto,
Mes Prolif
18.6 (+)
ing stromal cells. Tubules were easily and completely separated
from interstitial or inflammatory cells (Fig. 3).
HIV-1 target sequences were amplified from some of the
glomeruli, tubular and infiltrating inflammatory cells, but not
from interstitial cells from the kidney biopsies from HIV
infected patients with and without renal disease (Table 2). The
possibility that the negative findings for interstitial cells could
have been due to the presence of an inhibitor or that the
samples of interstitial cells contained too few cells to be
detected by the PCR techniques was excluded by coamplifying
a fragment of exon 1 of the MyHC gene. A PCR signal was
obtained from the latter in all samples including those of
interstitial cells.
All autopsy tissue from HIV infected patients without evi-
dence of renal disease showed the presence of HIV genome in
at least one microdissected sample. No HIV-1 target sequence
was amplified from any renal biopsy tissue from non-HIV
infected patients that was microdissected between the process-
ing of samples from HIV infected patients, indicating that
cross-contamination between specimens did not occur.
The observation that none of the samples of interstitial cells
contained HIV- 1 genome was important, since it provided
evidence of cellular localization of HIV-1 proviral DNA in the
tissue specimens. Because of the technical difficulty involved in
microdissecting individual interstitial cells, it was not possible
to prepare more than one sample of interstitial cells from each
tissue specimen. However, the number of interstitial cells
present in each sample approximately equalled the number of
cells present in each sample of tubular cells (12 to 15 interstitial
cells per sample compared with 2 to 3 tubules per sample with
6 to 8 cells per tubule). If the frequency of HIV. 1 proviral DNA
was actually the same between interstitial cells and tubular
cells, then the frequency of HIV- 1 proviral DNA in tubular cells
[41% (30/74)] versus that in interstitial cells [0% (0/15)] should
not be statistically significantly different. These two frequencies
did, however, differ at a level of significance of P < 0.002 (Chi
square and Fisher exact tests).
Discussion
HIV nephropathy is a heterogeneous syndrome dispropor-
tionately affecting Black males. Although approximately half
the patients with HIV infection and nephrotic range proteinuria
in our study had FGS, a substantial proportion had a form of
proliferative glomerulonephritis. These findings are consistent
with the notion of a spectrum of renal pathological outcomes,
including glomerulonephritis, associated with various clinical
renal syndromes in patients with HIV infection cited in reviews
[1—31 and other case series [8]. Such glomerulonephritis may be
intimately associated with the HIV infection as a result of
immune complex disease [16].
Regardless of pathological outcome, the HIV genome ap-
pears to be ubiquitous in renal tissue of patients with HIV
infection and nephrotic range proteinuria. The significance of
this finding is not clear. The presence of the HIV genome does
not determine the type of renal disease, as suggested by our
data and the work of Cohen et al [26]. They found proviral HIV
DNA in tubular and glomerular epithelial cells in biopsies and
autopsy tissue from HIV infected patients with renal disease
using in vitro DNA hybridization techniques. They also found
such markers, albeit less frequently, in HIV infected patients
Abbreviations are: FGS, focal segmental glomerulosclerosis; TIN,
tubular interstitial nephritis; MCD, minimal change disease; ATN,
acute tubular necrosis; IgA, IgA nephropathy; MN, membranous
nephropathy; MP, membranoproliferative; Mes Prolif, mesangial pro-
liferation; B, Black; M, male; HMS, homosexual; HTS, heterosexual;
TX, transplant; ND, not determined; DP, diffuse proliferative; FP, focal
proliferative; DM, diabetes mellitus; Crypto, cryptococcal nephritis;
GN, glomerulonephritis; W, white; F, female; BIS, bisexual; and
IVDU, intravenous drug user.
target sequences were amplified from 95.5% of the evaluated
HIV infected patients' biopsied tissue. None of the tissue from
patients without risk factors for the development of AIDS
showed evidence of the presence of HIV DNA. MyHC target
sequences were amplified from all the samples evaluated. These
results demonstrate that HIV-l proviral genome could only be
amplified from the HIV-positive archival material.
To determine the type of cell or cells that harbored the HIV- 1
target sequence, a microdissection technique was performed.
Each individual specimen of microdissected cells consisted of
either a single glomerulus, two to three tubules, a cluster of 10
to 12 mononuclear inflammatory cells, or 12 to 15 individually
dissected interstitial cells. Interstitial cells were present in the
interstitium as individual cells with scant cytoplasm and round
or ovoid nuclei that contained fine, evenly dispersed chromatin
(Fig. 1). Interstitial cells differed from those identified as
inflammatory cells by the fact that the latter occurred in clusters
and in infiltrates within the interstitium, and demonstrated
hyperchromatic molded nuclei that were somewhat smaller
than the nuclei of interstitial cells (Fig. 2). Samples of micro-
dissected tubules consisted of a simple circular arrangement of
six to eight tubular epithelial cells without associated underly-
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Fig. 1. Interstitial cell. An interstitial cell is identified by arrows in (A). A micropipette is subsequently used to dislodge the cell from the tissue
section (B). The histologic section after microdissection of the interstitial cell (C). None of the adjacent cells have been disturbed by the
microdissection procedure (all original magnifications X 400).
Fig. 2. Infiltrating infia,nmatory cells. The arrows in the upper left portion of (A) identify several lymphocytes in a group of infiltrating
inflammatory cells. (B) A micropipette is used to dislodge the inflammatory cells for subsequent PCR analysis. (C) Arrows point to the location
previously occupied by the microdissected inflammatory cells (all original magnifications X 400).
Fig. 3. Renal tubule. A renal tubule is
identified by the two arrows pointing at the
outer circumference of the tubule at the top of
(A). Four inflammatory cells are identified
with arrows at the bottom of the panel. (B)
The tissue section following removal of the
tubule by microdissection. None of the
adjacent inflammatory cells have been
disturbed by the microdissection procedure
(all original magnifications X 400).
with immune complex glomerulonephritis. However, the find-
ing of HIV genomic markers in renal tissue and specific cell
types may be critically dependent on the screening techniques
employed. Immunochemical studies, in situ hybridization and
PCR may exhibit different threshold sensitivities, and results
may vary with the reagents and techniques employed. PCR is
likely to be the most sensitive technique.
In addition, HIV genome may be detected in renal tissue of
HIV infected patients without clinical or pathologic evidence of
renal disease. This notion is supported by the results of our
investigations in autopsy tissue of HIV infected patients who
died without clinical or light microscopic evidence of renal
disease, and the finding of positive PCR in HIV-infected dia-
betic patients with diabetic nephropathy. Regarding the
latter patients, however, it is possible that the renal disease
might represent a subclinical, superimposed form of HIV-
associated renal disease, or that the HIV infection may have
aggravated the onset of early diabetic nephropathic changes.
The finding of HIV genomic material in autopsy tissue of
patients without light microscopic evidence of renal disease
indicates the presence of HIV genome may be necessary but
not sufficient for the development of HIV nephropathy. Cohen
et al were also able to demonstrate lilY nucleic acid in
non-lymphoid cells of HIV infected patients with renal disease
using in situ hybridization [26]. In their studies, in contrast to
ours, biopsies from HIV infected patients without renal disease
showed little evidence for the presence of viral nucleic acid in
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Table 2. Amplification of HIV gag gene from microdissected tissue
Patient Pathology
Microdissected cells
G T I IN
HIV positive
#1 Immune complex GN 2/6 2/3 0/1 ND
#2 IgA nephropathy 0/0 2/4 0/1 ND
#3 IgA nephropathy 3/5 2/5 0/1 1/1
#4 Immune complex GN 0/0 2/6 0/1 ND
#5 Focal glomerulosclerosis 5/6 1/3 0/1 1/1
#6 Minimal change disease 1/5 2/7 0/1 ND
#7 Diabetic glomerulosclerosis 5/9 1/5 0/1 ND
#8 Immune complex GN 0/0 2/5 0/1 ND
#9 Immune complex GN 4/6 3/8 0/1 1/1
#10 Focal glomerulosclerosis 2/6 0/4 0/1 0/1
HIV positive
autopsy
#1 Normal 6/6 2/5 0/1 1/1
#2 Normal 5/6 3/5 0/1 ND
#3 Normal 6/6 3/5 0/1 1/1
#4 Normal 6/6 2/5 0/1 ND
#5 Normal 4/6 3/4 0/1 ND
HIV negative
autopsy
#11 Diabetic glomerulosclerosis 0/4 0/3 0/1 ND
#12 Focal glomerulosclerosis 0/5 0/4 0/1 0/1
#13 Focal glomerulosclerosis 0/4 0/5 0/1 ND
#14 IgA nephropathy 0/5 0/4 0/1 ND
#15 Immune complex GN 0/6 0/3 0/1 ND
#16 Focal glomerulosclerosis 0/3 0/4 0/1 ND
#17 Immune complex GN 0/4 0/4 0/1 ND
#18 IgA nephropathy 0/4 0/5 0/1 ND
#19 Immune complex GN 0/4 0/4 0/1 ND
#20 Immune complex GN 0/5 0/3 0/1 ND
Abbreviations are: G, glomerulus; T, tubule; I, interstitial; IN,
inflammatory infiltrating cells; GN, glomerulonephritis; ND, not deter-
mined.
procedure used in our studies, however, their findings and those
in this report are consistent.
Our microdissection studies, however, suggest that the find-
ing of HIV genome in renal tissue may not be solely the result
of vascular proximity, or a consequence of circulating or
infiltrating inflammatory cells. Which renal cells may be subject
to infection by HIV is currently controversial. Recent prelimi-
nary evidence suggests HIV may infect renal tissue, specifically
endothelial [311 and mesangial cells [3 l—33], in vitro. We found
evidence of HIV genome in isolated glomeruli, and microdis-
sected tubular cells, and in renal parenchymal inflammatory
infiltrates in HIV infected patients with and without renal
disease. However, we did not elicit a positive PCR in micro-
dissected interstitial tissue, uninvolved with inflammatory cel-
lular infiltrate. These findings are consistent with differential
human immunodeficiency viral infectivity of renal cells. Such
concepts have been supported by the work of Cohen et al [26]
and Green, Resnick and Bourgoignie [311.
Our current findings do not identify which cell type within the
glomerulus contains the viral genome. The data of Green et al
[31] indicate that either mesangial cells or endothelial cells
could be infected, although Alpers, McClure and Burstein [34]
were unable to infect mesangial cells in vitro. Further studies
using more refined microdissection approaches or in situ PCR
may be required to resolve this issue. Our data confirm the
observation of Cohen et al [26] regarding the presence of HIV
nucleic acid in renal tubular epithelial cells.
The role of cellular incorporation of the HIV genome in the
development of renal disease and the pathogenic significance of
viral nucleic acid in a particular cell type are unknown. Simi-
larly, the role of viral genome in the pathogenesis of FGS and
other HIV related renal diseases is unknown. We have recently
demonstrated a high prevalence of abnormal glomerular and
tubular proteinuna in HIV infected patients, at different stages
of infection, regardless of risk factor for infection and demo-
graphic parameters [35]. However, the majority of patients
without evidence of clinical renal disease did not have abnormal
microalbuminuria. Such findings are consistent with the ubiq-
uitious finding and distribution of HIV genome in glomerular
and tubular tissue in HIV infected patients with and without
renal disease. Preliminary studies from our laboratories have
shown transforming growth factor-J3 increases HIV LTR ex-
pression in transfected human mesangial cells [33]. HIV
genomic material, in renal cells, under proper conditions, might
result in the increased production of matrix components. Alter-
natively, local disordered cytokine production, perhaps the
combined result of viral infection and genetic predisposition,
might modulate pathologic responses. In addition, we have
shown the presence of HIV proviral DNA in tissue from
patients with proliferative glomerulonephritis and immune com-
plex renal disease [16, 25]. In those cases, immune complex
disease may be associated with circulating immune complex
deposition or in situ mechanisms of disease. The finding of HIV
genome in renal tissue makes the possibility of in situ mecha-
nisms of immune complex nephropathy more likely. Such
mechanisms may operate whether HIV genetic material is
introduced in renal tissue by renal cellular infection or second-
ary to the presence of infiltrating HIV infected inflammatory
cells.
The reason for disproportionate prevalence of HIV associ-
ated nephropathy in specific populations [27] is also unknown.
The finding of HIV proviral DNA in renal tissue of HIV infected
patients both with and without renal disease suggests some
triggering mechanism such as an intercurrent viral infection [36,
37] may be responsible for the development of nephropathy. It
is possible that host factors might be related to immune or
genetic responses to HIV genomic material that could be
associated with the pathogenesis of a specific renal disease [16,
25, 26, 35, 38]. The role of growth factors in disease pathogen-
esis in different susceptible patient populations remains to be
determined.
Renal biopsy is necessary for the precise diagnosis of patients
with HIV infection who present with nephrotic range protein-
uria, regardless of demographic background. Such information
might be crucial to establishing prognosis, and to establish
rational treatment strategies and clinically-applicable treatment
protocols.
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